Reliable Gene Expression Measurements from Fine Needle Aspirates of Pancreatic Tumors: Effect of Amplicon Length and Quality Assessment

• Autores: Michelle A. Anderson, Dean E. Brenner, James M. Scheiman
• Localización: The Journal of molecular diagnostics, ISSN 1525-1578, Vol. 12, Nº 5, 2010, págs. 566-575
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Background and aims: Biomarker use for pancreatic cancer diagnosis has been impaired by a lack of samples suitable for reliable quantitative RT-PCR (qRT-PCR). Fine needle aspirates (FNAs) from pancreatic masses were studied to define potential causes of RNA degradation and develop methods for accurately measuring gene expression. Methods: Samples from 32 patients were studied. RNA degradation was assessed by using a multiplex PCR assay for varying lengths of glyceraldehyde-3-phosphate dehydrogenase, and effects on qRT-PCR were determined by using a 150-bp and a 80-bp amplicon for RPS6. Potential causes of and methods to circumvent RNA degradation were studied by using FNAs from a pancreatic cancer xenograft. Results: RNA extracted from pancreatic mass FNAs was extensively degraded. Fragmentation was related to needle bore diameter and could not be overcome by alterations in aspiration technique. Multiplex PCR for glyceraldehyde-3-phosphate dehydrogenase could distinguish samples that were suitable for qRT-PCR. The use of short PCR amplicons (<100 bp) provided reliable gene expression analysis from FNAs. When appropriate samples were used, the assay was highly reproducible for gene copy number with minimal (0.0003 or about 0.7% of total) variance. Conclusions: The degraded properties of endoscopic FNAs markedly affect the accuracy of gene expression measurements. Our novel approach to designate specimens �informative� for qRT-PCR allowed accurate molecular assessment for the diagnosis of pancreatic diseases.